TA
PFE icon

Tactive Advisors’s Pfizer PFE Stock Holding History

Tactive Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$370K Buy
+13,339
New +$370K 0.2% 84

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Tactive Advisors's PFE Position: Q1 2024 in Review

Tactive Advisors opened a new position in Pfizer (PFE) in Q1 2024: 13,339 shares worth $370K. The stake represents 0.2% of the portfolio and ranks #84 among its holdings.

2,883 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Tactive Advisors held 13,339 shares of Pfizer worth $370K as of Q1 2024.
  • Pfizer was a new Tactive Advisors position in Q1 2024.
  • Pfizer made up 0.2% of Tactive Advisors's portfolio in Q1 2024, its #84 holding.
  • 2,883 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Tactive Advisors's 13F filing for Q1 2024, filed 4 Jun 2024.